BILOXI, Miss., April 11, 2016 — A new USDA analysis of the Food and Drug Administration’s import refusals report reveals that the FDA rejected tens of thousands of imported seafood shipments because they were unfit for human consumption.
From 2005 to 2013, nearly 18,000 shipments were refused entry into the United States for containing unsafe levels of “filth,” veterinary drug residues and Salmonella, which is responsible for thousand hospitalizations per year and hundreds of deaths. “Filth” is a catchall term used to describe anything that shouldn’t be in food—like rat feces, parasites, illegal antibiotics and glass shards.
The USDA summarized their findings by saying, "The safety of imported seafood clearly continues to be of significant concern, based on the number of shipments refused by FDA."
Currently, the majority of all food refusals are seafood products; while the FDA is responsible for ensuring the safety of any food imported from foreign countries, they only have the manpower to inspect less than 1 percent of the 1.2 billion pounds of shrimp entering into the country each year.
The American Shrimp Processors Association (ASPA), a group representing the US Gulf and Southeast Atlantic Coast shrimp fishing industry, has expressed great concern over the findings. Dr. David Veal, the President of ASPA, was quoted as saying, “This issue goes beyond the FDA; I don’t think it’s unreasonable to expect food suppliers to take some responsibility for the health and safety of their products.” While there are a few more FDA inspectors now than a couple years ago, the ratio of shipments to inspectors is still impossibly high. Veal continued, “We hope shrimp exporters will take a more proactive role in assuring that suppliers adhere to laws designed to protect the people who buy their products.”
Shrimp is the most popular seafood in the United States, with the average person consuming more than four pounds of shrimp per year. Worryingly, 90 percent, or 3.6 of those pounds, will be imports from countries like China, Indonesia and Thailand, who routinely distribute shrimp that the FDA ends up refusing.
According to the report, Indonesia and Thailand account for about a fifth of shrimp refusals, and they’re also two of the largest exporters of shrimp to the United States. Moreover, while the report contains information through 2013, in more recent years other countries like India have greatly increased the amount of shrimp they export; in 2015, 297 million pounds of Indian shrimp was turned away.
While information is unavailable on the total number of FDA seafood inspections performed yearly, it is safe to assume that with the extremely low rates of inspection, Americans are consuming imported shrimp that is fundamentally unfit for consumption.
Safety and taste-conscious shrimp buyers are encouraged to purchase wild-caught domestic shrimp, which has demonstrably fewer bacterial and chemical contaminants, and is an important historic industry supporting millions of American jobs. Dr. Veal closed by saying; “Don’t wait until you get sick to start ask questions about where your shrimp is coming from. Things aren’t going to change unless more people realize the gamble they’re taking by eating imported shrimp.”
The American Shrimp Processors Association (ASPA), based in Biloxi, Mississippi, was formed in 1964 to represent and promote the interests of the domestic, U.S. wild-caught, warm water shrimp processing industry along the Gulf and South Atlantic with members from Texas to North Carolina. We are the collective voice of the industry, and our focus is to promote the interests of shrimp processors, other segments of the U.S. domestic wild-caught warm water shrimp industry and the general public.


Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Federal Judge Restores Funding for Gateway Rail Tunnel Project
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Federal Reserve Faces Subpoena Delay Amid Investigation Into Chair Jerome Powell
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



